<ul>
<li>DocGo：2023 年上漲的成長股</li>
</ul>
<p>DocGo Inc.（NASDAQ:DCGO - 免費報告）- Northland Capmk 在 11 月 10 日星期一發布的研究報告中下調了 DocGo 2026 年第三季度每股收益（EPS）預期。Northland Capmk 分析師 M. Latimore 現在預計該公司本季度每股收益為$0.00，低於之前的$0.03。DocGo 當前全年的共識預期收益為每股$0.25。Northland Capmk 還對 DocGo 2026 年第四季度的收益預期為每股$0.00。</p>
<p>DocGo（NASDAQ:DCGO - 獲取免費報告）在 11 月 10 日星期一最後一次公佈了其收益結果。該公司報告本季度每股收益為（$0.11），低於共識預期的（$0.09）$0.02。DocGo 的淨利潤率為負的 14.02%，股本回報率為負的 8.80%。該公司本季度的收入為 7081 萬美元，而分析師的預期為 6996 萬美元。DocGo 已設定其 2025 財年的每股收益指導。</p>
<p>其他幾家研究公司也最近對 DCGO 發表了看法。Zacks Research 在 11 月 6 日星期四的研究報告中將 DocGo 的評級從 “強烈賣出” 上調至 “持有”。Canaccord Genuity Group 在週三的報告中重申了對 DocGo 的 “買入” 評級。最後，Weiss Ratings 在 10 月 8 日星期三的研究報告中重申了對 DocGo 的 “賣出（d）” 評級。兩位投資分析師對該股票給予了買入評級，四位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，DocGo 的平均評級為 “持有”，平均目標價為$3.21。</p>
<p><strong>獲取我們關於 DCGO 的最新股票報告</strong></p>
<h2>DocGo 價格表現</h2>
<p>DocGo 股票在星期三開盤價為$1.10。該公司的 50 日移動平均價格為$1.31，200 日移動平均價格為$1.49。DocGo 的年低為$0.97，年高為$5.68。該公司的市值為$1.0759 億，市盈率為-2.12，貝塔值為 0.93。</p>
<h2>機構投資者對 DocGo 的看法</h2>
<p>一些機構投資者最近增加或減少了對該股票的持股。GSA Capital Partners LLP 在第三季度將其在 DocGo 的持股增加了 39.9%。GSA Capital Partners LLP 現在擁有 317,745 股該公司的股票，價值 432,000 美元，此前在上個季度購買了 90,571 股。摩根大通在第三季度將其在 DocGo 的持股提高了 92.0%。摩根大通現在擁有 557,613 股該公司的股票，價值 758,000 美元，此前在上個季度購買了 267,259 股。SG Americas Securities LLC 在第三季度將其在 DocGo 的持股增加了 23.5%。SG Americas Securities LLC 現在擁有 169,174 股該公司的股票，價值 230,000 美元，此前在上個季度購買了 32,209 股。懷俄明州在第二季度將其在 DocGo 的持股增加了 113.3%。懷俄明州現在擁有 264,793 股該公司的股票，價值 416,000 美元，此前在上個季度購買了 140,670 股。最後，Oxford Asset Management LLP 在第二季度將其在 DocGo 的持股提高了 122.6%。Oxford Asset Management LLP 現在擁有 93,126 股該公司的股票，價值 146,000 美元，此前在上個季度購買了 51,298 股。56.44% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>DocGo 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>DocGo Inc 為美國和英國的各種醫療保健提供者提供移動健康和醫療運輸服務。該公司的運輸服務包括緊急響應服務；非緊急運輸服務包括救護車和輪椅運輸服務。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票比 DocGo 更好</li>
<li>什麼是成長股及其投資</li>
<li>西方石油在 2025 年第四季度是一個買入</li>
<li>超買股票解釋：你應該交易它們嗎？</li>
<li>3 只被打壓的股票在本財報季有反彈潛力</li>
<li>股票分紅削減發生，你準備好了嗎？</li>
<li>如果市場再次下跌，亞馬遜是最明確的買入之一</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RENHTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RENHTw"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 DocGo 嗎？</h2>
<p>在考慮 DocGo 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 DocGo 並不在名單上。</p>
<p>雖然 DocGo 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

DCGO

<p>Northland Capmk 將 DocGo 的 2026 年第三季度每股收益預期從 $0.03 下調至 $0.00。DocGo 報告的第三季度每股收益為 ($0.11)，未能達到市場共識預期。分析師對 DocGo 的評級不一，平均評級為 “持有”，目標價格為 $3.21。機構投資者已調整在 DocGo 的持股比例，該公司在美國和英國提供移動健康服務</p>

<ul>
<li>DocGo: A Growth Stock Going Higher In 2023</li>
</ul>
<div class="lb-trans"><ul>
<li>DocGo：2023 年上漲的成長股</li>
</ul>
</div><p>DocGo Inc. (NASDAQ:DCGO - Free Report) - Northland Capmk reduced their Q3 2026 earnings per share (EPS) estimates for shares of DocGo in a research note issued on Monday, November 10th. Northland Capmk analyst M. Latimore now anticipates that the company will earn $0.00 per share for the quarter, down from their prior estimate of $0.03. The consensus estimate for DocGo's current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo's Q4 2026 earnings at $0.00 EPS.</p>
<div class="lb-trans"><p>DocGo Inc.（NASDAQ:DCGO - 免費報告）- Northland Capmk 在 11 月 10 日星期一發布的研究報告中下調了 DocGo 2026 年第三季度每股收益（EPS）預期。Northland Capmk 分析師 M. Latimore 現在預計該公司本季度每股收益為$0.00，低於之前的$0.03。DocGo 當前全年的共識預期收益為每股$0.25。Northland Capmk 還對 DocGo 2026 年第四季度的收益預期為每股$0.00。</p>
</div><p>DocGo (NASDAQ:DCGO - Get Free Report) last announced its earnings results on Monday, November 10th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by ($0.02). DocGo had a negative net margin of 14.02% and a negative return on equity of 8.80%. The business had revenue of $70.81 million for the quarter, compared to analysts' expectations of $69.96 million. DocGo has set its FY 2025 guidance at EPS.</p>
<div class="lb-trans"><p>DocGo（NASDAQ:DCGO - 獲取免費報告）在 11 月 10 日星期一最後一次公佈了其收益結果。該公司報告本季度每股收益為（$0.11），低於共識預期的（$0.09）$0.02。DocGo 的淨利潤率為負的 14.02%，股本回報率為負的 8.80%。該公司本季度的收入為 7081 萬美元，而分析師的預期為 6996 萬美元。DocGo 已設定其 2025 財年的每股收益指導。</p>
</div><p>Several other research firms have also recently weighed in on DCGO. Zacks Research upgraded shares of DocGo from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, November 6th. Canaccord Genuity Group restated a &#34;buy&#34; rating on shares of DocGo in a report on Wednesday. Finally, Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of DocGo in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, DocGo has an average rating of &#34;Hold&#34; and an average target price of $3.21.</p>
<div class="lb-trans"><p>其他幾家研究公司也最近對 DCGO 發表了看法。Zacks Research 在 11 月 6 日星期四的研究報告中將 DocGo 的評級從 “強烈賣出” 上調至 “持有”。Canaccord Genuity Group 在週三的報告中重申了對 DocGo 的 “買入” 評級。最後，Weiss Ratings 在 10 月 8 日星期三的研究報告中重申了對 DocGo 的 “賣出（d）” 評級。兩位投資分析師對該股票給予了買入評級，四位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，DocGo 的平均評級為 “持有”，平均目標價為$3.21。</p>
</div><p><strong>Get Our Latest Stock Report on DCGO</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 DCGO 的最新股票報告</strong></p>
</div><h2>DocGo Price Performance</h2>
<div class="lb-trans"><h2>DocGo 價格表現</h2>
</div><p>DocGo stock opened at $1.10 on Wednesday. The business has a fifty day moving average price of $1.31 and a 200-day moving average price of $1.49. DocGo has a one year low of $0.97 and a one year high of $5.68. The firm has a market capitalization of $107.59 million, a P/E ratio of -2.12 and a beta of 0.93.</p>
<div class="lb-trans"><p>DocGo 股票在星期三開盤價為$1.10。該公司的 50 日移動平均價格為$1.31，200 日移動平均價格為$1.49。DocGo 的年低為$0.97，年高為$5.68。該公司的市值為$1.0759 億，市盈率為-2.12，貝塔值為 0.93。</p>
</div><h2>Institutional Investors Weigh In On DocGo</h2>
<div class="lb-trans"><h2>機構投資者對 DocGo 的看法</h2>
</div><p>A number of institutional investors have recently added to or reduced their stakes in the stock. GSA Capital Partners LLP boosted its holdings in shares of DocGo by 39.9% during the 3rd quarter. GSA Capital Partners LLP now owns 317,745 shares of the company's stock valued at $432,000 after purchasing an additional 90,571 shares during the last quarter. JPMorgan Chase &amp; Co. lifted its position in shares of DocGo by 92.0% in the third quarter. JPMorgan Chase &amp; Co. now owns 557,613 shares of the company's stock worth $758,000 after buying an additional 267,259 shares in the last quarter. SG Americas Securities LLC boosted its stake in DocGo by 23.5% during the third quarter. SG Americas Securities LLC now owns 169,174 shares of the company's stock valued at $230,000 after buying an additional 32,209 shares during the last quarter. State of Wyoming grew its holdings in DocGo by 113.3% during the 2nd quarter. State of Wyoming now owns 264,793 shares of the company's stock valued at $416,000 after buying an additional 140,670 shares in the last quarter. Finally, Oxford Asset Management LLP raised its holdings in shares of DocGo by 122.6% during the 2nd quarter. Oxford Asset Management LLP now owns 93,126 shares of the company's stock worth $146,000 after acquiring an additional 51,298 shares in the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些機構投資者最近增加或減少了對該股票的持股。GSA Capital Partners LLP 在第三季度將其在 DocGo 的持股增加了 39.9%。GSA Capital Partners LLP 現在擁有 317,745 股該公司的股票，價值 432,000 美元，此前在上個季度購買了 90,571 股。摩根大通在第三季度將其在 DocGo 的持股提高了 92.0%。摩根大通現在擁有 557,613 股該公司的股票，價值 758,000 美元，此前在上個季度購買了 267,259 股。SG Americas Securities LLC 在第三季度將其在 DocGo 的持股增加了 23.5%。SG Americas Securities LLC 現在擁有 169,174 股該公司的股票，價值 230,000 美元，此前在上個季度購買了 32,209 股。懷俄明州在第二季度將其在 DocGo 的持股增加了 113.3%。懷俄明州現在擁有 264,793 股該公司的股票，價值 416,000 美元，此前在上個季度購買了 140,670 股。最後，Oxford Asset Management LLP 在第二季度將其在 DocGo 的持股提高了 122.6%。Oxford Asset Management LLP 現在擁有 93,126 股該公司的股票，價值 146,000 美元，此前在上個季度購買了 51,298 股。56.44% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>DocGo Company Profile</h2>
<div class="lb-trans"><h2>DocGo 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.</p>
<div class="lb-trans"><p>DocGo Inc 為美國和英國的各種醫療保健提供者提供移動健康和醫療運輸服務。該公司的運輸服務包括緊急響應服務；非緊急運輸服務包括救護車和輪椅運輸服務。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than DocGo</li>
<li>What Are Growth Stocks and Investing in Them</li>
<li>Occidental Petroleum is a Buy in Q4 2025</li>
<li>Overbought Stocks Explained: Should You Trade Them?</li>
<li>3 Beaten-Down Stocks With Rebound Potential This Earnings Season</li>
<li>Stock Dividend Cuts Happen Are You Ready?</li>
<li>Amazon Is One of the Clearest Buys If the Market Dips Again</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票比 DocGo 更好</li>
<li>什麼是成長股及其投資</li>
<li>西方石油在 2025 年第四季度是一個買入</li>
<li>超買股票解釋：你應該交易它們嗎？</li>
<li>3 只被打壓的股票在本財報季有反彈潛力</li>
<li>股票分紅削減發生，你準備好了嗎？</li>
<li>如果市場再次下跌，亞馬遜是最明確的買入之一</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RENHTw" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NASDAQ&amp;Symbol=DCGO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in DocGo Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 DocGo 嗎？</h2>
</div><p>Before you consider DocGo, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 DocGo 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 DocGo 並不在名單上。</p>
</div><p>While DocGo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 DocGo 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Northland Capmk 對 DocGo 的收益發布了負面預估